Amit Bahl
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators, Jonnada S, Gannon M, Gale J, Eswar C, Douis H, Din O, Birtle A, Bahl A, Khaksar S, Lester J, O'Sullivan J, Sydes M, Parmar M, Tran A, Srihari N, Sheehan D, Pudney D, Pedley I, Parikh O, Alonzi R, Amos C, Thalmann G, Chowdhury S, Attard G, Ritchie A, Ali A, Hoyle A, Clarke N, Brawley C, James N, Cross W, Dearnaley D, Gillessen Sommer S, Russell J, Millman R, Matheson D, Mason M, Malik Z, Langley R, Jones R, Gilson C, Parker C. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet 2018; 392:2353-2366.
21.10.2018Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
21.10.2018Lancet 2018; 392:2353-2366
Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators, Jonnada Sai, Gannon Melissa R, Gale Joanna, Eswar Chinnamani, Douis Hassan, Din Omar, Birtle Alison, Bahl Amit, Khaksar Sara, Lester Jason F, O'Sullivan Joe M, Sydes Matthew R, Parmar Mahesh K B, Tran Anna T H, Srihari Narayanan Nair, Sheehan Denise J, Pudney Delia M, Pedley Ian D, Parikh Omi A, Alonzi Roberto, Amos Claire L, Thalmann George N, Chowdhury Simon, Attard Gerhardt, Ritchie Alastair W S, Ali Adnan, Hoyle Alex P, Clarke Noel W, Brawley Christopher D, James Nicholas D, Cross William, Dearnaley David P, Gillessen Sommer Silke, Russell J Martin, Millman Robin, Matheson David, Mason Malcolm D, Malik Zafar I, Langley Ruth E, Jones Robert J, Gilson Clare, Parker Christopher C
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
Fitzpatrick J, Fosså S, Gillessen Sommer S, Kellokumpu-Lehtinen P, Lecouvet F, Oudard S, de Reijke T, Robson C, De Santis M, Seruga B, Finn S, Efstathiou E, Bellmunt J, Fizazi K, Heidenreich A, Sternberg C, Tombal B, Alcaraz A, Bahl A, Bracarda S, Di Lorenzo G, de Wit R. Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel. Eur J Cancer 2014; 50:1617-27.
03.04.2014Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
03.04.2014Eur J Cancer 2014; 50:1617-27
Fitzpatrick John M, Fosså Sophie, Gillessen Sommer Silke, Kellokumpu-Lehtinen Pirkko-Liisa, Lecouvet Frédéric E, Oudard Stephane, de Reijke Theo M, Robson Craig N, De Santis Maria, Seruga Bostjan, Finn Stephen P, Efstathiou Eleni, Bellmunt Joaquim, Fizazi Karim, Heidenreich Axel, Sternberg Cora N, Tombal Bertrand, Alcaraz Antonio, Bahl Amit, Bracarda Sergio, Di Lorenzo Giuseppe, de Wit Ronald